Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00673933 · ClinicalTrials.gov registry record · Phase 2

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

A Phase 2 study of Acne Vulgaris, sponsored by Photocure.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target
2
Study locations

NCT00673933 is a Phase 2 study of Acne Vulgaris that has completed, run by Photocure. The registered enrollment target is 20 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00673933, a Phase 2 study of Acne Vulgaris, has completed, sponsored by Photocure.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

Conditions Studied

Acne Vulgaris

Interventions

  • DRUG Methyl aminolevulinate (MAL) PDT

Study Locations (2)

Illinois

  • DuPage Medical Group - Naperville

New Mexico

  • Academic Dermatology Associates - Albuquerque

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-05
Est. Completion 2008-12
Phase Phase 2

Sponsor

Photocure

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00673933

The ClinicalTrials.gov registry entry for NCT00673933 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (93% lower). The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Methyl aminolevulinate (MAL) PDT is the first listed.

NCT00673933 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, New Mexico.

Frequently Asked Questions

What is clinical trial NCT00673933 about?

NCT00673933 is a clinical study titled "Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris". In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

What is the current status of trial NCT00673933?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2008-05. Estimated completion is 2008-12.

What conditions does trial NCT00673933 study?

This clinical trial studies the following conditions: Acne Vulgaris.

What interventions are being tested in trial NCT00673933?

The interventions under investigation include: Methyl aminolevulinate (MAL) PDT (DRUG).

Who is sponsoring clinical trial NCT00673933?

This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00673933 being conducted?

This trial has 2 study locations across Illinois, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acne Vulgaris

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.